Lazard Asset Management’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,368
Closed -$146K 2461
2023
Q1
$146K Buy
3,368
+197
+6% +$8.7K ﹤0.01% 1401
2022
Q4
$118K Buy
3,171
+760
+32% +$29.4K ﹤0.01% 1464
2022
Q3
$95K Buy
2,411
+825
+52% +$30.5K ﹤0.01% 1494
2022
Q2
$60K Buy
1,586
+338
+27% +$12.2K ﹤0.01% 1731
2022
Q1
$49K Buy
+1,248
New +$48.9K ﹤0.01% 1749

Other funds holding NRC

Lazard Asset Management's NRC Position: Q2 2023 in Review

Lazard Asset Management sold out of NRC Health Common Stock (NRC) in Q2 2023, closing a stake of 3,368 shares — an estimated $146K sold.

Lazard Asset Management first reported a position in NRC in Q1 2022 and held it in 5 quarters. The position peaked at $146K in Q1 2023. 116 funds tracked by Wall St. Rank hold NRC as of Q2 2023.

  • Lazard Asset Management reported no remaining NRC Health Common Stock position as of Q2 2023 after selling out during the quarter.
  • Lazard Asset Management sold 3,368 NRC Health Common Stock shares in Q2 2023, an estimated $146K.
  • Lazard Asset Management first reported a position in NRC Health Common Stock in Q1 2022 and held it in 5 quarters.
  • Lazard Asset Management's NRC Health Common Stock position peaked at $146K in Q1 2023.
  • 116 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2023.

Based on Lazard Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.